Ilex Medical (ILX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.068x

Based on the latest financial reports, Ilex Medical (ILX) has a cash flow conversion efficiency ratio of 0.068x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA44.77 Million ≈ $120.02K USD) by net assets (ILA660.36 Million ≈ $1.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ilex Medical - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Ilex Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Ilex Medical for a breakdown of total debt and financial obligations.

Ilex Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ilex Medical ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
BriQ Properties Real Estate Investment Company
AT:BRIQ
0.005x
HIM International Music
TWO:8446
0.069x
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK
-0.098x
Kotra Industries Bhd
KLSE:0002
0.017x
TRUFIN PLC
F:29U
N/A
Dmc Global Inc
NASDAQ:BOOM
-0.006x
Lindsay Australia Ltd
AU:LAU
0.093x
Proficient Auto Logistics, Inc. Common Stock
NASDAQ:PAL
0.040x

Annual Cash Flow Conversion Efficiency for Ilex Medical (2008–2024)

The table below shows the annual cash flow conversion efficiency of Ilex Medical from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see ILX market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA646.49 Million
≈ $1.73 Million
ILA81.63 Million
≈ $218.85K
0.126x -2.12%
2023-12-31 ILA623.51 Million
≈ $1.67 Million
ILA80.43 Million
≈ $215.64K
0.129x +13.41%
2022-12-31 ILA613.10 Million
≈ $1.64 Million
ILA69.74 Million
≈ $186.97K
0.114x -75.81%
2021-12-31 ILA575.57 Million
≈ $1.54 Million
ILA270.68 Million
≈ $725.67K
0.470x +14.35%
2020-12-31 ILA443.54 Million
≈ $1.19 Million
ILA182.40 Million
≈ $489.02K
0.411x +56.71%
2019-12-31 ILA323.48 Million
≈ $867.23K
ILA84.89 Million
≈ $227.58K
0.262x +31.43%
2018-12-31 ILA293.49 Million
≈ $786.83K
ILA58.60 Million
≈ $157.11K
0.200x -30.04%
2017-12-31 ILA266.15 Million
≈ $713.53K
ILA75.96 Million
≈ $203.65K
0.285x +446.57%
2016-12-31 ILA244.51 Million
≈ $655.52K
ILA12.77 Million
≈ $34.23K
0.052x -73.88%
2015-12-31 ILA225.99 Million
≈ $605.87K
ILA45.17 Million
≈ $121.11K
0.200x -48.76%
2014-12-31 ILA204.60 Million
≈ $548.53K
ILA79.81 Million
≈ $213.98K
0.390x +275.55%
2013-12-31 ILA214.38 Million
≈ $574.74K
ILA22.27 Million
≈ $59.70K
0.104x -50.83%
2012-12-31 ILA259.96 Million
≈ $696.93K
ILA54.92 Million
≈ $147.23K
0.211x +17.88%
2011-12-31 ILA282.99 Million
≈ $758.68K
ILA50.71 Million
≈ $135.96K
0.179x -44.23%
2010-12-31 ILA120.80 Million
≈ $323.87K
ILA38.82 Million
≈ $104.08K
0.321x -17.86%
2009-12-31 ILA127.32 Million
≈ $341.33K
ILA49.81 Million
≈ $133.54K
0.391x +47.29%
2008-12-31 ILA109.44 Million
≈ $293.42K
ILA29.07 Million
≈ $77.94K
0.266x --

About Ilex Medical

TA:ILX Israel Medical Devices
Market Cap
$141.31 Million
ILA52.71 Billion ILA
Market Cap Rank
#17948 Global
#230 in Israel
Share Price
ILA4711.00
Change (1 day)
+1.53%
52-Week Range
ILA4620.00 - ILA7080.00
All Time High
ILA15645.73
About

Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine micros… Read more